1933 Industries (TSE:TGIF)
:TGIF
Top Page
1933 Industries
(TGIF)
Select Model
Select Model
Rating:48Neutral
Price Target:
C$0.02
▲(50.00% Upside)
Action:ReiteratedDate:03/25/26
The score is held back primarily by high financial risk from negative equity and meaningful debt, despite an improving profitability and cash-flow trend. Technicals show positive momentum but appear stretched (high RSI/Stoch), while valuation is moderate (P/E ~13.4) with no dividend support provided.
Positive Factors
Improving cash generation
Sustained positive operating and free cash flow provides a durable internal funding source for operations and reinvestment. Over 2–6 months this supports working capital, funds modest capex, and enables gradual debt repayment without relying on equity raises that dilute shareholders.
Negative Factors
Negative equity
Negative shareholders’ equity is a structural capital weakness that elevates insolvency risk and constrains strategic options. It limits access to capital markets, complicates refinancing, and can force asset sales or dilutive financing if cash generation weakens.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving cash generation
Sustained positive operating and free cash flow provides a durable internal funding source for operations and reinvestment. Over 2–6 months this supports working capital, funds modest capex, and enables gradual debt repayment without relying on equity raises that dilute shareholders.
Read all positive factors
1933 Industries (TGIF) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$4.96M
Dividend YieldN/A
Average Volume (3M)94.62K
Price to Earnings (P/E)13.4
Beta (1Y)-2.83
Revenue Growth-2.30%
EPS GrowthN/A
CountryCA
Employees85
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)0.00
Shares Outstanding495,975,100
10 Day Avg. Volume87,184
30 Day Avg. Volume94,616
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)-1.07
Price to Sales (P/S)0.28
P/FCF Ratio2.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
1933 Industries Business Overview & Revenue Model
Company Description
1933 Industries Inc., a cannabis company, engages in the cultivation and production of cannabis products in the United States and Canada. The company produces, packages, and markets of cannabidiol (CBD)-infused products. It operates in the medical...
How the Company Makes Money
null...
1933 Industries Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
18
Very Negative
Cash Flow
61
Positive
| Breakdown | Oct 2025 | Jan 2025 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 17.45M | 19.35M | 18.27M | 12.54M | 11.98M |
| Gross Profit | 5.16M | 2.94M | -4.22M | 2.69M | 4.82M |
| EBITDA | 1.01M | 313.67K | -10.03M | -13.83M | -2.71M |
| Net Income | -217.04K | -1.14M | -13.36M | -18.07M | -6.29M |
Balance Sheet | |||||
| Total Assets | 16.80M | 16.87M | 18.02M | 29.01M | 45.35M |
| Cash, Cash Equivalents and Short-Term Investments | 545.98K | 449.18K | 1.09M | 363.27K | 4.41M |
| Total Debt | 17.60M | 16.78M | 17.57M | 17.68M | 17.87M |
| Total Liabilities | 21.40M | 21.70M | 23.28M | 21.49M | 20.12M |
| Stockholders Equity | -4.60M | -3.53M | -3.69M | 8.52M | 25.99M |
Cash Flow | |||||
| Free Cash Flow | 1.67M | 801.71K | -2.33M | -5.10M | -5.12M |
| Operating Cash Flow | 1.84M | 1.69M | -1.53M | -5.09M | -4.67M |
| Investing Cash Flow | -169.22K | -890.78K | 2.33M | 1.58K | -456.36K |
| Financing Cash Flow | -1.58M | -1.46M | -266.55K | 1.53M | 6.06M |
1933 Industries Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | C$9.90M | -9.82 | -167.41% | ― | 55.74% | -27.59% | |
48 Neutral | C$4.96M | 13.38 | ― | ― | -2.30% | ― | |
45 Neutral | C$10.00M | 5.19 | ― | ― | 15.64% | 58.47% | |
43 Neutral | C$4.22M | -3.90 | -9.77% | ― | 13.01% | -2445.45% | |
43 Neutral | C$6.59M | -3.18 | ― | ― | -100.00% | -192.62% |
* Healthcare Sector Average
TSE:TGIF
1933 Industries
0.01
0.00
0.00%
TSE:DHB
Delivra Health Brands
0.14
-0.04
-25.00%
TSE:BBM
Blueberries Medical
0.02
0.01
100.00%
TSE:PCLO
PharmaCielo
0.07
0.00
0.00%
TSE:SPR
Sproutly Canada
0.02
0.00
0.00%
TSE:SE
Sweet Earth Holdings
0.51
-0.02
-3.77%
1933 Industries Corporate Events
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
1933 Industries Cuts Debt via Debenture Conversions but Warns on Liquidity Strain
Negative
Dec 30, 2025
1933 Industries has announced that holders converted $1.035 million of its unsecured 2024 convertible debentures into equity units by the December 22, 2025 deadline, leaving $1.563 million in debentures still outstanding. The conversions have redu...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.